Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer

by Aishwarya Pawar, Paradesi Naidu Gollavilli, Shaomeng Wang, Irfan A. Asangani
Published 2018-02-01

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

by Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan A. Asangani
Published 2021-03-01

The Role of Sarcosine Metabolism in Prostate Cancer Progression

by Amjad P Khan, Thekkelnaycke M Rajendiran, Ateeq Bushra, Irfan A Asangani, Jyoti N Athanikar, Anastasia K Yocum, Rohit Mehra, Javed Siddiqui, Ganesh Palapattu, John T Wei, George Michailidis, Arun Sreekumar, Arul M Chinnaiyan
Published 2013-05-01

Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression

by Rui Wang, Irfan A Asangani, Balabhadrapatruni VSK Chakravarthi, Bushra Ateeq, Robert J Lonigro, Qi Cao, Mani Ram-Shankar, Daniel F Camacho, Natalie McGregor, Taibriana EW Schumann, Xiaojun Jing, Radhika Menawat, Scott A Tomlins, Heng Zheng, Arie P Otte, Rohit Mehra, Javed Siddiqui, Saravana M Dhanasekaran, Mukesh K Nyati, Kenneth J Pienta, Nallasivam Palanisamy, Lakshmi P Kunju, Mark A Rubin, Arul M Chinnaiyan, Sooryanarayana Varambally
Published 2012-10-01